logo

Quick Facts

Share SHARE

Pfizer Inc. (PFE) said that the REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin (bevacizumab), met its primary objective. PF-06439535 is being developed by Pfizer as a potential biosimilar to Avastin. The trial demonstrated equivalence...

Merck & Co. Inc. (MRK) announced Monday the U.S. launch of RENFLEXIS (infliximab-abda), a biosimilar of the originator biologic medicine Remicade (infliximab). RENFLEXIS was approved by the U.S. Food and Drug Administration on April 21 for all eligible indications. RENFLEXIS is the first medicine...

ParkerVision, Inc. (PRKR), a manufacturer of semiconductor technology solutions for wireless applications, provided an update to its on-going patent licensing program by saying it has re-filed its claims against LG Electronics (LGEPF.OB, LGEJY.OB, LGEIY.OB, LGEAF.OB) and related entities in the District...

Lennox International Inc. (LII) announced the company raised the low end of its 2017 adjusted EPS from continuing operations guidance to $7.75-$8.15 from $7.55-$8.15. The company narrowed guidance for GAAP EPS from continuing operations to $7.73-$8.13 from $7.65-$8.25. For 2017, Lennox raised 2017 guidance...

Cytori Therapeutics Inc. (CYTX) announced preliminary data from its pivotal STAR trial of HabeoTM Cell Therapy in patients with scleroderma. While the primary endpoint, Cochin Hand Function Score (CHFS), did not reach statistical significance at 24 or 48 weeks, the trial data reported clinically meaningful...

Eli Lilly and Co. (LLY) and Nektar Therapeutics (NKTR) Monday announced a strategic collaboration to co-develop NKTR-358, an immunological therapy discovered by Nektar. The compound is intended to reat a number of autoimmune and other chronic inflammatory conditions. Under the terms of the agreement,...

VF Corp. (VFC) announced that Eric Wiseman will retire as Executive Chairman of the Board and as a Director, effective October 28, 2017. VF's Board has elected President, Chief Executive Officer and Director Steven Rendle, to the role of Chairman effective upon Wiseman's retirement. Wiseman began...

Genocea Biosciences Inc. (GNCA) announced positive 12-month top-line data from the Phase 2b clinical trial for GEN-003, its immunotherapy candidate for patients with genital herpes. In this 131-subject Phase 2b clinical trial, GEN-003 reduced the median genital lesion rate (or percent days with genital...

Bristol-Myers Squibb Company (BMY) announced the U.S. FDA has expanded the indication for Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatric patients 12 years of age and older. The company said the U.S. FDA approval marks...

Teleflex Inc. (TFX), a provider of medical technologies for critical care and surgery, announced that its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration. The new Seldinger Arterial Catheterization Device is indicated for short-term...

Applied Materials Inc. (AMAT) Monday announced the appointment of Dan Durn as chief financial officer, effective August 24, replacing Bob Halliday. Durn will join on August 7 as senior vice president. The company said Halliday will remain with the company, moving to new role focused on business...

The Carlyle Group (CG) announced it is selling majority control of The Nature's Bounty Co., a global manufacturer, marketer and distributor of health and wellness products, to KKR. Following the transaction, KKR will be the majority owner of Nature's Bounty while Carlyle will retain a significant stake...

WebMD Health Corp. (WBMD), a KKR portfolio company, announced that Internet Brands has entered into a definitive agreement to acquire WebMD in a transaction valued at approximately $2.8 billion. A subsidiary of Internet Brands will commence a tender offer in the next 10 business days to acquire all of...

VF Corp. (VFC) announced its fiscal 2017 earnings per share is now expected to be $2.94, down approximately 1 percent on a reported basis (up at a mid-single-digit percentage rate currency neutral) compared to 2016. This compares to the company's prior outlook range of $2.89 to $2.94. VF Corp. noted...

Huntsman Corp. (HUN) announced its subsidiary, Venator Materials PLC, launched its initial public offering of its ordinary shares, which will be listed on the NYSE in August under the ticker symbol, VNTR. The initial public offering consists of 22.7 million of its ordinary shares at an anticipated initial...

Follow RTT